logo-loader
Aphria

Aphria rebuffs Green Growth Brand's hostile takeover bid

The potential takeover would have had 'negative repercussions, including delisting from the TSX and NYSE and a potential reduction in interest from strategic partners,' according to Aphria

merger metaphor
Aphria's board called US rival Green Growth a company with 'limited' operations

Aphria Inc shares (NYSE:APHA) slid Wednesday after the Canadian cannabis producer rebuffed US rival Green Growth Brands Inc’s hostile takeover bid on the view that it “significantly undervalued” the company and is “inadequate”.

Green Growth first put an offer to buy Aphria on the table in December, which was also rejected, and then last month, introduced a second nearly identical unsolicited bid for Aphria, which put its value at roughly C$2.35 billion (US:$1.76 bn).

READ: Green Growth Brands pursues Aphria with second hostile bid

On Wednesday, Aphria issued a statement saying its board had moved to reject the hostile bid, arguing that it would have given Green Growth shareholders a 36% interest in Aphria in exchange for shares in a company with "limited" operations.

“The Aphria Board of Directors unanimously believes that GGB’s hostile offer is significantly undervalued and inadequate and not in the interest of Aphria shareholders on multiple grounds,” said Irwin Simon, Aphria’s board chairman in a statement.

The potential takeover would also have had “negative repercussions, including delisting from the TSX and NYSE and a potential reduction in interest from strategic partners,” according to the statement.

Aphria’s shares took a hit last December in the wake of the release of a critical report from short sellers Quintessential Capital Management and Hindenburg Research, which cast doubt on the company’s dealings in Latin America. In response to the criticism, Aphria’s board appointed a special committee to investigate the short-sellers’ allegations.

News of Aphria’s rejection of Green Growth’s bid also comes at a time of uncertainty for Aphria’s management. Last month, Aphria’ said its CEO and co-founder Vic Neufeld will step down from the company’s helm.

Investors failed to applaud the news, sending Aphria shares down 6.16% to $10.05 before the opening bell on Wednesday.

Contact Ellen Kelleher at [email protected]

Quick facts: Aphria

Price: $8.17

Market: TSX
Market Cap: $2.05 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Arcadia Biosciences makes major progress on its hemp venture...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive the California-based company expects to “significantly scale revenues in 2020” as it reported financial and business results for the second quarter and first half of 2019. Ketkar says the agricultural innovation company made...

2 days, 10 hours ago

2 min read